HALISTER: Hologic to Divest Blood Screening to Grifols for $1.85b Cash

Hologic to Divest Blood Screening to Grifols for $1.85b Cash

(Bloomberg) -- Hologic to sell blood-screening business to long-time commercial partner; Grifols to get a fully paid-up license to certain IP for use in the blood screening field.
  • HOLX halted
Statement: Link
Alert: HALISTER
Source: BFW (Bloomberg First Word)

Tickers
GRF SM (Grifols SA)
HOLX US (Hologic Inc)

To de-activate this alert, click here

UUID: 7947283